Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Jun 1;24(1):280.
doi: 10.1186/s13054-020-02984-6.

Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study

Affiliations
Multicenter Study

Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study

Dimitri Titeca-Beauport et al. Crit Care. .

Erratum in

Abstract

Background: The urine biomarkers tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) have been validated for predicting and stratifying AKI. In this study, we analyzed the utility of these biomarkers for distinguishing between transient and persistent AKI in the early phase of septic shock.

Methods: We performed a prospective, multicenter study in 11 French ICUs. Patients presenting septic shock, with the development of AKI within the first 6 h, were included. Urine [TIMP-2]*[IGFBP7] was determined at inclusion (0 h), 6 h, 12 h, and 24 h. AKI was considered transient if it resolved within 3 days. Discriminative power was evaluated by receiver operating characteristic (ROC) curve analysis.

Results: We included 184 patients, within a median [IQR] time of 1.0 [0.0-3.0] h after norepinephrine (NE) initiation; 100 (54%) patients presented transient and 84 (46%) presented persistent AKI. Median [IQR] baseline urine [TIMP-2]*[IGFBP7] was higher in the persistent AKI group (2.21 [0.81-4.90] (ng/ml)2/1000) than in the transient AKI group (0.75 [0.20-2.12] (ng/ml)2/1000; p < 0.001). Baseline urine [TIMP-2]*[IGFBP7] was poorly discriminant, with an AUROC [95% CI] of 0.67 [0.59-0.73]. The clinical prediction model combining baseline serum creatinine concentration, baseline urine output, baseline NE dose, and baseline extrarenal SOFA performed well for the prediction of persistent AKI, with an AUROC [95% CI] of 0.81 [0.74-0.86]. The addition of urine [TIMP-2]*[IGFBP7] to this model did not improve the predictive performance.

Conclusions: Urine [TIMP-2]*[IGFBP7] measurements in the early phase of septic shock discriminate poorly between transient and persistent AKI and do not improve clinical prediction over that achieved with the usual variables.

Trial registration: NCT02812784.

Keywords: Acute kidney injury; Biomarkers; Recovery; Septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interest to declare.

Figures

Fig. 1
Fig. 1
Study flow chart. RRT, renal replacement therapy; AKI, acute kidney injury
Fig. 2
Fig. 2
a Change in AKI severity over the first 72 h. The vertical bar indicates the AKI stage at inclusion according to the KDIGO classification. Horizontal bars indicate changes in the AKI stage over 72 h according to the AKI stage at inclusion. b Change in AKI severity and mortality in the transient and persistent AKI groups, over the first 72 h. The bars indicate the AKI stage and the proportion of patients dead at inclusion, 24 h, 48 h, and 72 h of follow-up
Fig. 3
Fig. 3
Box plots of the baseline, 6 h, 12 h, and 24 h urine [TIMP-2]*[IGFBP7] values. Log-transformed data area shown. The boxes and whiskers correspond to interquartile ranges and total ranges, respectively. Each dot represents an individual value. Urine [TIMP-2]*[IGFBP7] was significantly higher in patients with persistent AKI than in those with transient AKI. At baseline (n = 184), median [IQR] value of 2.21 [0.81–4.90] vs. 0.75 [0.20–2.12] (ng/ml)2/1000 (p < 0.001); at 6 h (n = 172), median [IQR] value of 2.02 [0.54–5.43] vs. 0.37 [0.13–1.38] (ng/ml)2/1000 (p < 0.001); at 12 h (n = 165), median [IQR] value of 1.19 [0.30–3.8] vs. 0.33 [0.13–0.78] (ng/ml)2/1000 (p < 0.001); and at 24 h (n = 156), median [IQR] value of 0.69 [0.26–2.36] vs. 0.32 [0.12–0.86] (ng/ml)2/1000 (< 0.001). TIMP-2, tissue inhibitor of metalloproteinases-2; IGFBP-7, insulin-like growth factor-binding protein 7; AKI, acute kidney injury; IQR, interquartile range

Similar articles

Cited by

References

    1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–818. doi: 10.1001/jama.294.7.813. - DOI - PubMed
    1. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2:431–439. doi: 10.2215/CJN.03681106. - DOI - PubMed
    1. Peters E, Antonelli M, Wittebole X, Nanchal R, François B, Sakr Y, et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from the Intensive Care Over Nations audit. Crit Care. 2018;22:188. doi: 10.1186/s13054-018-2112-z. - DOI - PMC - PubMed
    1. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422–427. doi: 10.1038/ki.2009.159. - DOI - PubMed
    1. Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz A-C, et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care. 2013;17:R278. doi: 10.1186/cc13133. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data